Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PURVI S PARIKH

Allopathic & Osteopathic Physicians Allergy & Immunology

NPI
1629212592
CMS profile
73969
Location
NEW YORK, NY

General Payments · PY2018–2024

$167,689.54

  • Reported across 210 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$33,301.02

24 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Genentech USA, Inc. $14,464.33 14
GlaxoSmithKline, LLC. $7,318.53 4
NOVARTIS PHARMACEUTICALS CORPORATION $4,887.50 1
Acerta Pharma LLC $4,833.00 1
GENZYME CORPORATION $1,797.66 4

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $32,133.05 53
PY2019 $34,559.53 49
PY2020 $9,551.83 8
PY2021 $5,222.14 6
PY2022 $24,008.99 32
PY2023 $28,912.98 38
PY2024 $33,301.02 24

Payment records · PY2024 (24)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $4,833.00 10/08/2024 Consulting Fee Undisputed 01/23/2026 1105536406 CMS
Genentech USA, Inc. $880.00 03/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1133090901 CMS
Genentech USA, Inc. $32.92 07/30/2024 Travel and Lodging Undisputed 01/23/2026 1133090857 CMS
Genentech USA, Inc. $537.43 07/30/2024 Travel and Lodging Undisputed 01/23/2026 1133090861 CMS
Genentech USA, Inc. $147.63 07/30/2024 Food and Beverage Undisputed 01/23/2026 1133090865 CMS
Genentech USA, Inc. $3,000.00 07/30/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1133090869 CMS
Genentech USA, Inc. $59.34 08/05/2024 Food and Beverage Undisputed 01/23/2026 1133090849 CMS
Genentech USA, Inc. $52.12 08/05/2024 Travel and Lodging Undisputed 01/23/2026 1133090853 CMS
Genentech USA, Inc. $3,000.00 08/05/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1133090873 CMS
Genentech USA, Inc. $15.00 11/27/2024 Travel and Lodging Undisputed 01/23/2026 1133090893 CMS
Genentech USA, Inc. $99.78 12/03/2024 Food and Beverage Undisputed 01/23/2026 1133090885 CMS
Genentech USA, Inc. $547.53 12/03/2024 Travel and Lodging Undisputed 01/23/2026 1133090897 CMS
Genentech USA, Inc. $92.58 12/10/2024 Food and Beverage Undisputed 01/23/2026 1133090877 CMS
Genentech USA, Inc. $3,000.00 12/19/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1133090881 CMS
Genentech USA, Inc. $3,000.00 12/19/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1133090889 CMS
GENZYME CORPORATION $161.18 03/27/2024 Food and Beverage Undisputed 01/23/2026 1139603542 CMS
GENZYME CORPORATION $1,599.00 03/27/2024 Consulting Fee Undisputed 01/23/2026 1139603544 CMS
GENZYME CORPORATION $33.22 03/27/2024 Travel and Lodging Undisputed 01/23/2026 1139603546 CMS
GENZYME CORPORATION $4.26 04/30/2024 Food and Beverage Undisputed 01/23/2026 1139603548 CMS
GlaxoSmithKline, LLC. $7,150.00 01/18/2024 Consulting Fee Undisputed 01/23/2026 1116327154 CMS
GlaxoSmithKline, LLC. $76.55 02/13/2024 Travel and Lodging Undisputed 01/23/2026 1116146526 CMS
GlaxoSmithKline, LLC. $86.98 02/13/2024 Travel and Lodging Undisputed 01/23/2026 1116439375 CMS
GlaxoSmithKline, LLC. $5.00 02/13/2024 Food and Beverage Undisputed 01/23/2026 1116546115 CMS
Novartis Pharmaceuticals Corporation $4,887.50 10/26/2024 Consulting Fee Undisputed 01/23/2026 1087343533 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.